Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population

R GrieselP SinxadiA KawumaJ JoskaSimiso SokhelaGodspower AkpomiemieWillem VenterE et al2024-07-232024-07-23WOS0305-7453https://hdl.handle.net/10539/39030Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African populationJournal Article